RADRADIOPHARM THERANOSTICS LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 20 Aug 2026, 18:51 | RAD advances to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Trial | Company Update | MS | 11001 | |
| 18 Aug 2026, 02:52 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 17 Aug 2026, 19:02 | RAD to meet with US FDA to align on RAD 101 Phase 3 Trial | Company Update | MS | 11001 | |
| 13 Aug 2026, 18:22 | Notice of Extraordinary General Meeting and Proxy Form | Meetings & Governance | — | 08002, 08004 | |
| 7 Aug 2026, 19:38 | Share Purchase Plan - Now Open | Capital Raising | — | 06017, 16002 | |
| 5 Aug 2026, 23:56 | Update - Proposed issue of securities - RAD | Securities Administration | — | 06013 | |
| 3 Aug 2026, 20:51 | Application for quotation of securities - RAD | Other | — | 06020 | |
| 31 July 2026, 21:19 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 31 July 2026, 02:48 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 31 July 2026, 02:32 | Target market determination (TMD) | Other | — | 14001 | |
| 31 July 2026, 02:25 | Prospectus | Capital Raising | — | 06003, 06010, 06017, 16002 | |
| 29 July 2026, 02:19 | Notice Under Section 708A | Securities Administration | — | 06018 | |
| 28 July 2026, 20:53 | Application for quotation of securities - RAD | Other | — | 06020 | |
| 25 July 2026, 03:21 | Reinstatement to Quotation | Reinstatement | MS | 09002 | |
| 25 July 2026, 03:21 | Investor Presentation - Capital Raising | Capital Raising | — | 03026, 06003, 06009, 06017 | |
| 25 July 2026, 03:21 | Proposed issue of securities - RAD | Securities Administration | — | 06013 | |
| 25 July 2026, 03:20 | Proposed issue of securities - RAD | Securities Administration | — | 06013 | |
| 25 July 2026, 03:20 | RAD completes A$12.5 M placement and launches A$6 M SPP | Capital Raising | MS | 06003, 06009, 06017 | |
| 24 July 2026, 19:14 | Suspension from Quotation | Trading Halt / Suspension | MS | 09001 | |
| 22 July 2026, 19:04 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 22 July 2026, 18:32 | RAD Achieves Partial Response in Phase 1 Trial of RAD204 | Company Update | MS | 11001 | |
| 22 July 2026, 18:22 | RAD Announces Positive Phase 2b Trial Results of RAD 101 | Company Update | MS | 11001 | |
| 4 July 2026, 01:20 | Radiopharm Receives $5.9M R&D Tax Incentive | Periodic Reports | — | 03014 | |
| 1 July 2026, 02:15 | Notification regarding unquoted securities - RAD | Other | — | 06021 | |
| 1 July 2026, 02:05 | Notification of cessation of securities - RAD | Other | — | 06027 | |
| 3 June 2026, 22:08 | Notification of cessation of securities - RAD | Other | — | 06027 | |
| 1 May 2026, 19:53 | Financial Services and Company Secretary Changes | Company Administration | — | 12007, 12008 | |
| 23 Apr 2026, 19:04 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 20 Apr 2026, 18:54 | RAD Initial Findings from Phase 1 177Lu-RAD202 Trial | Company Update | — | 11001, 12008 | |
| 16 Apr 2026, 18:41 | RAD Completes Enrollment in Phase 2b Trial of RAD 101 | Company Update | MS | 11001 | |
| 8 Apr 2026, 19:00 | RAD202 Phase 1 HEAT Trial Advances to Dose Level 3 | Company Update | MS | 11001 | |
| 7 Apr 2026, 18:31 | RAD and Siemens Sign Clinical Supply Agreement for RAD101 | Company Update | — | 11001 | |
| 1 Apr 2026, 02:53 | Change of Director's Interest Notice (IT) | Director Interests | — | 02009 | |
| 27 Mar 2026, 19:23 | RAD Doses First Patient in RAD 402 Phase 1 Clinical Study | Company Update | MS | 11001 | |
| 24 Mar 2026, 20:34 | RAD101 2nd interim Ph.2b data - 90% achieve primary endpoint | Company Update | MS | 11001, 14014 | |
| 19 Mar 2026, 21:08 | RAD to present at NWR Virtual Healthcare Conference | Company Administration | — | 12008 | |
| 28 Feb 2026, 00:03 | Half Year Report and Appendix 4D 31 December 2025 | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 24 Feb 2026, 20:25 | RAD Doses First Patient in 177Lu-BetaBart (RV-01) Study | Company Update | MS | 11001 | |
| 28 Jan 2026, 20:19 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 12 Jan 2026, 19:27 | RAD Increases Ownership in Radiopharm Ventures to 87.5% | Company Update | — | 11001 | |
| 7 Jan 2026, 21:58 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 23 Dec 2025, 21:27 | Notification of cessation of securities - RAD | Other | — | 06027 | |
| 20 Dec 2025, 04:29 | Change of Director's Interest Notice (RC) | Director Interests | — | 02009 | |
| 20 Dec 2025, 04:28 | Change of Director's Interest Notice (PH) | Director Interests | — | 02009 | |
| 20 Dec 2025, 04:26 | Change of Director's Interest Notice (IT) | Director Interests | — | 02009 | |
| 20 Dec 2025, 04:11 | Notification regarding unquoted securities - RAD | Other | — | 06021 | |
| 19 Dec 2025, 02:07 | Proposed issue of securities - RAD | Securities Administration | — | 06013 | |
| 19 Dec 2025, 01:42 | RAD announces establishment of At-The-Market Equity Facility | Securities Administration | — | 06009 | |
| 19 Dec 2025, 01:22 | Non-compliance with ASX Listing Rule 7.1 | Company Administration | — | 12008 | |
| 15 Dec 2025, 20:35 | RAD101 interim Phase 2b data - 92% achieve primary endpoint | Company Update | MS | 11001 |
1–50 of 99
1 / 2